Roche’s Enicepatide: A Game-Changer in the Obesity Drug Race
Roche, the Swiss pharmaceutical giant, announced on Friday that its experimental obesity drug, Enicepatide, has achieved significant weight…
Genentech obesity drugs post Phase II weight-loss data
See more from StockTitan in…
Roche obesity drugs post Phase II weight-loss data
Roche (OTCQX:RHHBY) will present new Phase II data from its obesity portfolio at…